glp-1 meds for weight loss Drugs Loss: The Good, Bad and Unknown Losing the Weight Loss Meds

GLP-1 (glucagon-like peptide-1) medications, such as semaglutide and tirzepatide, work by regulating appetite, slowing digestion, and improving blood sugar control

Do not give more often or in greater amounts than recommended

Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes

This is why attempting to maintain constant blood levels is both unnecessary and potentially wasteful

In turn, the overall BW loss, defined as achieving 5% and 10% reduction, was similar between men and women

Regarding bone metabolism, the resistance and combined groups showed significantly smaller declines in hip BMD (femoral neck, greater/lesser trochanter) compared to the aerobic and control groups, further supporting the advantages of resistance exercise in maintaining bone mass